US Patent Issued to GEn1E Lifesciences on April 7 for "Modulators of extracellular signal-regulated kinase" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,243, issued on April 7, was assigned to GEn1E Lifesciences Inc. (Palo Alto, Calif.).

"Modulators of extracellular signal-regulated kinase" was invented by Adam Galan (Alameda, Calif.), Ritu Lal (Palo Alto, Calif.) and Chakk Ramesha (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Modulators of extracellular signal-regulated kinase, pharmaceutical compositions thereof, and uses of the compound and pharmaceutical compositions thereof for treating cancer and pulmonary diseases are disclosed."

The patent was filed on Oct. 18, 2024, under Application No. 18/920,162.

*For further information, including images, charts and tables, please ...